Dicerna Pharmaceuticals
DRNA
#3610
Rank
โ‚ฌ2.84 B
Marketcap
36,50ย โ‚ฌ
Share price
0.00%
Change (1 day)
18,012.48%
Change (1 year)

Revenue for Dicerna Pharmaceuticals (DRNA)

Revenue in 2021 (TTM): โ‚ฌ0.16 Billion

According to Dicerna Pharmaceuticals's latest financial reports the company's current revenue is โ‚ฌ0.18 Billion. In 2020 the company made a revenue of โ‚ฌ0.15 Billion an increase over the revenue in the year 2019 that were of โ‚ฌ22.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dicerna Pharmaceuticals from 2017 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ0.16 B3.82%
2020โ‚ฌ0.15 B587.36%
2019โ‚ฌ22.82 M287.05%
2018โ‚ฌ5.89 M171.23%
2017โ‚ฌ2.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ18.76 M-89.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ53.13 B 28,752.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.00 B 986.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ59.66 B 32,297.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ31.06 B 16,770.11%๐Ÿ‡บ๐Ÿ‡ธ USA